Option Care Health (NASDAQ:OPCH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Option Care Health (NASDAQ:OPCH) had its price target upped by stock analysts at JPMorgan Chase & Co. from $38.00 to $40.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 32.31% from the company’s current price.

A number of other analysts have also commented on the company. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $35.00 in a report on Thursday. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research lifted their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. UBS Group started coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Finally, Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Stock Up 0.8 %

Shares of Option Care Health stock traded up $0.23 during trading hours on Friday, reaching $30.23. The company’s stock had a trading volume of 193,109 shares, compared to its average volume of 2,206,669. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock’s fifty day simple moving average is $24.26 and its two-hundred day simple moving average is $27.80. The company has a market capitalization of $5.14 billion, a P/E ratio of 25.40, a P/E/G ratio of 2.11 and a beta of 1.31. Option Care Health has a one year low of $21.39 and a one year high of $34.63.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in OPCH. UMB Bank n.a. lifted its holdings in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its holdings in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the period. International Assets Investment Management LLC grew its stake in Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares in the last quarter. Finally, Quarry LP raised its holdings in Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares during the period. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.